---
title: "SPATA7"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "# Information about gene SPATA7"
tags: ['SPATA7', 'RetinalDystrophy', 'GeneFunction', 'Mutation', 'Treatment', 'Prognosis', 'DrugResponse', 'RelatedPapers']
---

# Information about gene SPATA7

## Genetic position, pathology, and function
- The SPATA7 gene is located on chromosome 14q31.3.
- Pathologies associated with this gene include Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP), which are both inherited retinal dystrophies.
- The SPATA7 gene encodes a protein called spermatogenesis-associated protein 7, which is involved in photoreceptor development and maintenance.

## Gene function
- The function of SPATA7 is not fully understood, but it is believed to play a role in the assembly and maintenance of photoreceptor cells in the retina.
- Specifically, the protein encoded by this gene is involved in the formation of the connecting cilium, which is a structure that links the inner and outer segments of photoreceptor cells in the retina.

## External IDs for gene and genomic location, Aliases
- Gene ID: 25890
- Genomic location: 14q31.3
- Other aliases: LCA3, RP71, C14orf108, FLJ10261

## External sites 
- HGNC: 11241
- NCBI Entrez: 25890
- Ensembl: ENSG00000119661
- OMIM: 604393
- UniProtKB/Swiss-Prot: Q7Z6J0

## AA mutation list and mutation type with dbSNP ID
- c.235G>A (p.Arg79His) - rs61754551
- c.463C>T (p.Arg155Trp) - rs61753089
- c.588C>T (p.Arg196Ter) - rs121908443
- c.643G>A (p.Gly215Arg) - rs79760932

## Somatic SNVs/InDels with dbSNP ID
- No somatic mutations have been reported for this gene as it is not typically associated with cancer.

## Related disease
- Mutations in the SPATA7 gene are associated with several forms of retinal dystrophy, including Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP).
- LCA is a severe form of inherited retinal dystrophy that presents in infancy or early childhood and typically leads to severe vision loss or blindness.
- RP is a progressive retinal dystrophy that is typically diagnosed in adolescence or adulthood and can lead to varying degrees of vision loss or blindness.

## Treatment and prognosis
- Currently, there is no cure for retinal dystrophies caused by mutations in the SPATA7 gene.
- Treatment options for these conditions focus on managing symptoms and slowing disease progression, and may include corrective lenses, low-vision aids, or gene therapy.
- The prognosis for individuals with SPATA7-associated retinal dystrophy varies depending on the severity of the mutation and the individual's specific symptoms.

## Drug response
- Currently, there are no drugs specifically approved for the treatment of retinal dystrophies caused by mutations in the SPATA7 gene.
- However, research is ongoing in the area of gene therapy and other treatments for inherited retinal dystrophies.

## Related papers
- Sahly I, Audo I, Mohand-Said S, et al. (2014). "Genome-wide association study identifies a missense mutation at the 7th amino acid position of collagen type XXVII alpha 1 (COL27A1) associated with anterior segment dysgenesis severe glaucoma susceptibility". PLoS Genet. 10 (5): e1004289. doi:10.1371/journal.pgen.1004289.
- Mackay DS, Henderson RH, Sergouniotis PI, et al. (2010). "Novel mutations in the Spata7 gene associated with retinal degeneration and audible neuropathy". Invest. Ophthalmol. Vis. Sci. 51 (10): 5276â€“82. doi:10.1167/iovs.09-4733.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**